MARGHERI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.244
EU - Europa 4.372
AS - Asia 1.019
OC - Oceania 48
AF - Africa 31
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.725
Nazione #
US - Stati Uniti d'America 5.235
PL - Polonia 1.660
RU - Federazione Russa 1.246
IT - Italia 456
IE - Irlanda 354
SE - Svezia 287
SG - Singapore 238
HK - Hong Kong 232
CN - Cina 208
JO - Giordania 120
GB - Regno Unito 83
IN - India 79
FI - Finlandia 67
ID - Indonesia 57
DE - Germania 51
VN - Vietnam 48
AU - Australia 47
UA - Ucraina 41
BE - Belgio 29
CH - Svizzera 29
CI - Costa d'Avorio 23
FR - Francia 18
ES - Italia 14
AT - Austria 13
TR - Turchia 13
CA - Canada 8
NL - Olanda 8
KR - Corea 7
CZ - Repubblica Ceca 5
EU - Europa 4
JP - Giappone 4
CL - Cile 3
GR - Grecia 3
IR - Iran 3
SK - Slovacchia (Repubblica Slovacca) 3
BR - Brasile 2
EG - Egitto 2
IL - Israele 2
NO - Norvegia 2
PH - Filippine 2
TN - Tunisia 2
YE - Yemen 2
AM - Armenia 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
LV - Lettonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 10.725
Città #
Warsaw 1.660
Santa Clara 1.504
Fairfield 519
Chandler 432
Dublin 350
Ashburn 286
Woodbridge 234
Seattle 217
Ann Arbor 197
Singapore 193
Cambridge 189
Houston 182
Wilmington 162
Hong Kong 158
Florence 152
Altamura 106
Lawrence 103
Princeton 89
Jacksonville 61
Moscow 57
Buffalo 53
Jakarta 53
Mumbai 52
Beijing 51
Boardman 51
Shanghai 51
Melbourne 46
Medford 45
Boston 44
San Diego 42
Dong Ket 33
Brussels 29
Bern 24
Abidjan 23
Helsinki 17
New York 16
Kent 15
Norwalk 15
Barcelona 14
Pune 14
West Jordan 14
London 13
Phoenix 13
Vienna 12
Hillsboro 11
Los Angeles 11
Yubileyny 10
Zhengzhou 10
Izmir 9
Milan 9
Guangzhou 8
Redmond 8
Bari 7
Falls Church 7
Bremen 6
Fiesole 5
Hangzhou 5
Redwood City 5
Rome 5
Shenzhen 5
Toronto 5
Andover 4
Chiusi 4
Grafing 4
Olomouc 4
Prato 4
Salt Lake City 4
Seoul 4
Tappahannock 4
Wuhan 4
Auburn Hills 3
Bratislava 3
Cecina 3
Frankfurt Am Main 3
Genoa 3
Guwahati 3
Hanoi 3
Kilburn 3
Laurel 3
Palaiseau 3
Poggio a Caiano 3
Romola 3
Scandicci 3
Acton 2
Amsterdam 2
Bientina 2
Birmingham 2
Bologna 2
Bursa 2
Castel Ritaldi 2
Castelliri 2
Cologno Monzese 2
Dalian 2
Durham 2
Formigine 2
Frankfurt am Main 2
Groningen 2
Iquique 2
Irkutsk 2
Jiaxing 2
Totale 7.826
Nome #
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 298
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 291
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 290
The acidic microenvironment as a possible niche of dormant tumor cells 278
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 267
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 266
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 249
Type II CRISPR/Cas9 approach in the oncological therapy 242
Modulation of the Senescence-Associated Inflammatory Phenotype in Human Fibroblasts by Olive Phenols 232
Acidity of Microenvironment as a Further Driver of Tumor Metabolic Reprogramming 229
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 219
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 219
Oleuropein aglycone attenuates the pro-angiogenic phenotype of senescent fibroblasts: a functional study in endothelial cells 202
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 196
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 181
Anoikis resistance as a further trait of acidic-adapted melanoma cells 167
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 166
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 165
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 163
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 162
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 156
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 156
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 154
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 153
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 147
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. 145
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 141
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 139
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 134
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 133
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 130
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 130
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 124
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis 123
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 122
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 119
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 115
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 113
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 113
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 112
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 111
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 110
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 110
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 109
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 108
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation 105
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 104
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 102
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy 96
Colon fibroblasts from Pirc rats (F344/NTac-Apcam1137) exhibit a proliferative and inflammatory phenotype that could support early stages of colon carcinogenesis 91
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 89
Delivery systems of CRISPR/Cas9-based cancer gene therapy 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 85
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 84
Chronic treatment with resveratrol and olive oil phenols on MRC5 fibroblast SASP: inhibition of pro-tumoral microenvironment 84
Anti-urokinase receptor antisense oligonucleotide (uPar-aODN) to prevent and cure long-term space exploration related retinal pathological angiogenesis 82
Prep1 regulates angiogenesis through a PGC-1α-mediated mechanism 82
The protease systems and their pathogenic role in juvenile idiopathic arthritis. 81
Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes 80
Th17 lymphocyte-dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab 80
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 78
Cell-mediated release of nanoparticles as a preferential option for future treatment of melanoma 78
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent-Associated Secretory Phenotype" on endothelial colony-forming cells: The role of IL8 78
Plasticity in Endothelial Cells and Endothelial Progenitor Cells: uPAR-mediated Amoeboid Angiogenesis 78
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 78
Parvovirus B19 (B19V) induces cellular senescence in human dermal fibroblasts: putative role in SSc-associated fibrosis. 78
Olive phenols preserve lamin B1 expression reducing cGAS/STING/NFκB-mediated SASP in ionizing radiation-induced senescence. 76
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 75
Beta2-integrins anchor uPAR to the actin cytoskeleton in microvascular endothelial cells: critical role in angiogenesis 74
Water diffusion effects at gold-graphene interfaces supporting surface plasmon polaritons 73
A Possible Role for PAI-1 Blockade in Melanoma Immunotherapy 70
Dielectric-Loaded Waveguides as Advanced Platforms for Diagnostics and Application of Transparent Thin Films 67
Cleavage of urokinase receptor (CD87) and its defective association with cytoskeleton in systemic sclerosis endothelial cells result in impairment of angiogenesis in vitro 63
uPAR controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells. 63
The Interaction between reactive peritoneal mesothelial cells and tumor cells via extracellular vesicles facilitates colorectal cancer dissemination 63
miR-214-enriched extracellular vesicles released by acid-adapted melanoma cells promote inflammatory macrophage-dependent tumor trans-endothelial migration 63
RHEUMATOID SYNOVIAL FIBROBLASTS COSTITUTIVELY EXPRESS THE FIBRINOLITIC PATTERN OF INVASIVE TUMOR-LIKE CELLS 62
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis. 62
SYSTEMIC SCLEROSIS (SSC) FIBROBLASTS REDUCE ANGIOGENESIS IN HEALTHY MICROVASCULAR ENDOTHELIAL CELLS (H-MVEC) BY CLEAVAGE OF UROKINASE RECEPTOR (CD87, U-PAR) 59
Inhibition of 37/67kDa laminin-1 receptor restores APP maturation and reduces amyloid-β in human skin fibroblasts from familial alzheimer's disease 53
Retro-inverso collagen modulator peptide derived from Serpin A1 with enhanced stability and activity in vitro 53
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice 52
Pulsed-Laser-Driven CO2 Reduction Reaction for the Control of the Photoluminescence Quantum Yield of Organometallic Gold Nanocomposites 51
Synthesis and characterization of modified magnetic nanoparticles as theranostic agents: in vitro safety assessment in healthy cells 47
Characterization of urokinase receptor (CD87, uPAR) and its association with avb3-integrin in human microvascular endothelial cells (hMVECs): a morphological study 45
Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases 44
Failure of Beta2 integrin-mediated association between uPAR and cytoskeleton in systemic sclerosis microvascular endothelial cells. 43
The impairment of angiogenesis in systemic sclerosis (SSc) microvascular endothelial cells is associated with Metalloprotease 12 (MMP-12) dependent cleavage of urokinase receptor (uPAR) and with the defective association between uPAR and cytoskeleton 43
Impaired in vitro angiogenesis in systemic sclerosis (SSc) is associated with cleavage of urokinase receptor (CD87, uPAR) and its defective association with cytoskeleton 42
Failed uPAR-integrin-actin cytoskeleton association in systemic sclerosis endothelial cells results in impaired angiogenesis 41
Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells. 41
Divergent regulation of long non-coding RNAs H19 and PURPL affects cell senescence in human dermal fibroblasts. 40
Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment 38
Development of a retro-inverso tetrapeptide collagen modulator as anti-aging active principle 33
Totale 10.938
Categoria #
all - tutte 30.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020725 0 0 0 0 0 0 133 182 133 107 141 29
2020/20211.200 79 138 34 161 71 94 93 91 101 210 58 70
2021/2022639 27 62 48 32 23 25 30 57 32 27 111 165
2022/20231.814 145 361 63 160 136 282 213 125 227 9 51 42
2023/2024746 21 71 91 29 56 117 44 154 17 70 40 36
2024/20253.621 166 469 270 707 1.325 624 60 0 0 0 0 0
Totale 10.938